肿瘤血管靶向治疗,tumor vascular-targeted therapy
1)tumor vascular-targeted therapy肿瘤血管靶向治疗
1.Research development of solidtumor vascular-targeted therapy肿瘤血管靶向治疗的研究进展
英文短句/例句
1.Numerical Study of Tumor Hemodynamics for Vascular-targeted Therapy肿瘤血管靶向治疗的血液动力学数值研究
2.The application study of vascular endothelial growth factor and its receptor in tumor vascular targeting therapy of colorectal carcinoma;血管内皮生长因子及受体在大肠肿瘤血管靶向治疗中的应用研究
3.Target Therapy with Oncolytic Adenovirus for Cancer Stem Cell溶瘤腺病毒对肿瘤干细胞的靶向治疗
4.Research of Cognitive System Model in Tumor Targeted Therapy肿瘤靶向治疗精确靶向定位认知系统的研究
5.Cancer Gene Therapy by Targeting Survivin Pathway;靶向Survivin通路的肿瘤基因治疗
6.Advances on targeted therapy of tumor by superantigen超抗原及靶向治疗肿瘤作用进展(英文)
7.Evaluation of targeted argon-helium cryoablation in treating solid tumors氩氦刀靶向消融治疗实体肿瘤的评价
8.Progress and Clinical Evaluation of Tumor-Targeted Therapy Drugs肿瘤靶向治疗药物的进展与临床评价
9.The advances of erlotinib in cancer treatment厄罗替尼靶向治疗肿瘤临床研究进展
10.Experimental Study for Therapy of Human Breast Carcinoma by Tumor-targeted Induction of Apoptosis Combined with Anti-angiogenesis Strategy;靶向性诱导肿瘤细胞凋亡联合抑制血管生成治疗人乳腺癌的实验研究
11.The Identification of Vasculature Homing Peptide GX1 Specifically to Tumor Endothelial Cells in Vitro and in Vivo;肿瘤血管靶向肽GX1的体内外鉴定
12.Research progress of molecular-targeted ultrasonic imaging in angiogenesis and heterogeneity of tumors肿瘤血管生成异质性及肿瘤血管生成超声分子靶向成像研究进展
13.Treatment Based on Syndrome Differentiation and Molecular Targeted Therapy of Cancer论中医的辨证论治与肿瘤的分子靶向治疗
14.Basic Research of TRAIL Recombinant Live E.coli on Tumor-targeting Therapy;TRAIL重组活大肠杆菌肿瘤靶向治疗的基础研究
15.Study of Antitumor Effects of rmFⅦ-Gen Conjugate by Targeting Tissue Factor;rmFⅦ-Gen复合物靶向TF治疗肿瘤的实验研究
16.Experimental Research for Ar-He Targeted Cryosurgery in Lung Cancer;氩氦靶向冷冻治疗肺部肿瘤的实验研究
17.The Synthesis of a Targeted Anti-tumor Agent-sunitinib Malate;肿瘤靶向治疗药物苹果酸舒尼替尼的合成研究
18.The Preliminary Study of Neovasculature Endothelial Cells Targeted Tum-5 Gene for Tumor Therapy;靶向性重组Tum-5基因对肿瘤治疗的实验研究
相关短句/例句
target tumor therapy肿瘤靶向治疗
1.The progress of antitumor prodrug intarget tumor therapy;抗肿瘤前药在肿瘤靶向治疗中的新进展
3)targeting therapy for tumor靶向肿瘤治疗
4)Tumor-blood vessel-targeting肿瘤血管靶向
5)Endothelial cell-targeted therapy靶向血管治疗
6)Tumor anti-angiogenesis therapy抗血管靶向治疗
延伸阅读
靶向给药分子式：CAS号：性质：靶制剂选择性地与靶细胞结合产生药理效应的过程。由于不同的给药途径药靶物制剂可以进入不同的位置，而产后不同的靶向性和作用特点。如脂质体制剂，可以静脉、腹腔、肌肉、皮下或淋巴结注射，也可以支气管给药或大脑内、脊椎给药。静脉给药时，脂质体在体内优先被富含网状内皮细胞的组织（肝脾）所摄取，并迅速被单核吞噬细胞吞噬和降解。主要包括脂质体给药系统、受体靶向及磁性药物。脂质体制剂是把药物包裹在双分子脂质膜中，此种磷脂膜与生物膜类似，成为药物的载体，它与细胞膜亲和力强，使癌细胞摄取增多，提高疗效，增加耐受性。受体靶向是利用脂质体的表面有共价键与抗肿瘤细胞表面抗原的单克隆抗体结合，使脂质体在肿瘤细胞内大量集中，提高抗肿瘤细胞的选择性。磁性药物是指药物与高磁性的硫酸铁结合，在给药后，体外使用强大的磁场，使肿瘤部位处于此种强大磁场之下，药物被选择性地集中在肿瘤细胞，提高治疗指数。
